Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
Nathan J CheethamMilla KibbleAndrew WongRichard J SilverwoodAnika KnuppelDylan M WilliamsOlivia K L HamiltonPaul Hong LeeCharis Bridger StaatzGiorgio Di GessaJingmin ZhuSrinivasa Vittal KatikireddiGeorge B PloubidisEllen J ThompsonRuth C E BowyerXinyuan ZhangGolboo AbbasianMaria Paz GarciaDeborah HartJeffrey SeowCarl GrahamNeophytos KouphouSam AcorsMichael H MalimRuth E MitchellKate NorthstoneDaniel SmithSarah MatthewsThomas BreezeMichael CrawfordLynn MolloyAlex S F KwongKatie DooresNishi ChaturvediEmma L DuncanNicholas J TimpsonClaire J StevesPublished in: eLife (2023)
Antibody testing was funded by UK Health Security Agency. The National Core Studies program is funded by COVID-19 Longitudinal Health and Wellbeing - National Core Study (LHW-NCS) HMT/UKRI/MRC ([MC_PC_20030] and [MC_PC_20059]). Related funding was also provided by the NIHR 606 (CONVALESCENCE grant [COV-LT-0009]). TwinsUK is funded by the Wellcome Trust, Medical Research Council, Versus Arthritis, European Union Horizon 2020, Chronic Disease Research Foundation (CDRF), Zoe Ltd and the National Institute for Health Research (NIHR) Clinical Research Network (CRN) and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. The UK Medical Research Council and Wellcome (Grant ref: [217065/Z/19/Z]) and the University of Bristol provide core support for ALSPAC.